• Nicotine Signaling in Chronic Kidney Disease

  2026-08-25

  Jain and Jaimes’ review integrates clinical and experimental evidence that nicotine can accelerate chronic kidney disease through non-neuronal nicotinic acetylcholine receptors, oxidative stress, hemodynamic changes, and profibrotic signaling. Its main practical contribution is a mechanistic framework for separating nicotine-associated renal injury from the broader effects of cigarette smoke and for designing receptor-, oxidative stress-, and fibrosis-focused studies.

• Brassinolide Workflows for Plant and Cancer Research

  2026-08-25

  Brassinolide supports a distinctive cross-domain workflow: low-concentration plant bioassays on one side and mechanistic apoptosis studies in PC-3 cells on the other. This guide translates the evidence into practical preparation, assay-design, comparison, and troubleshooting strategies while keeping plant, cancer, and diabetes research conclusions appropriately separated.

• LNP Surface Charge and V-ATPase Drive Nucleic Acid Tropism

  2026-08-24

  This study proposes that lipid nanoparticle tropism is determined not only by particle surface charge but also by the V-ATPase activity of recipient cells. Its paired in vitro and in vivo experiments connect cellular endo/lysosomal state with organ-selective functional delivery, offering a framework for designing delivery systems around both vector properties and target biology.

• MCL-1 Dependence in Breast Cancer: Study Insights

  2026-08-23

  A 2021 Cell Death & Differentiation study shows that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic activity. Genetic loss and selective pharmacological inhibition both required BAX and BAK to produce antitumor effects, strengthening the rationale for apoptosis-focused MCL-1 research while defining important translational limits.

• Polyethylenimine Linear: PEI MW 40,000 Workflows

  2026-08-22

  Build reproducible DNA delivery workflows with Polyethylenimine Linear, PEI MW 40,000, from HEK-293 reporter assays to scalable recombinant protein production. The same optimization strategy can support mechanistic studies of astrocyte inflammation while keeping transfection effects separate from biological conclusions.

• Berberrubine, NF-κB, and RPE Chemokines

  2026-08-21

  The reference study showed that berberrubine suppresses interleukin-8 and monocyte chemotactic protein-1 production in cytokine-stimulated ARPE-19 retinal pigment epithelial cells. By combining protein assays, real-time PCR, and NF-κB localization analysis, it linked reduced chemokine output to diminished NF-κB nuclear translocation, while also illustrating the value and limits of an in vitro inflammatory model.

• Anisomycin for JNK Pathway and Apoptosis Studies

  2026-08-20

  Anisomycin provides a controllable JNK agonist workflow for separating rapid stress signaling from later apoptosis in cultured cells. This guide translates that design logic into cancer-cell assays while using a recent social-memory study to sharpen temporal controls without overstating cross-domain evidence.

• Mycophenolic Acid: A Translational Immunometabolism Lever

  2026-08-20

  Mycophenolic acid is more than a catalog reagent: as a dehydrogenase inhibitor, it provides a pathway-defined perturbation for studying nucleotide metabolism, cytokine responses, and immune-cell function. This thought-leadership guide translates standardized whole-blood stimulation into a rigorous strategy for assay design, validation, and translational interpretation.

• Oxaliplatin Resistance: A Mechanism-First Guide

  2026-08-19

  Oxaliplatin is a platinum-based chemotherapeutic agent whose DNA adducts connect molecular damage with apoptosis and treatment response. This guide interprets oxaliplatin resistance through the CCN2-LRP6-β-catenin-ABCG1 pathway and translates the evidence into more informative assay decisions.

• Triptolide (PG490): From Transcription to Translation

  2026-08-19

  Triptolide (PG490) offers translational researchers a powerful way to connect transcriptional control with cancer invasion, immune-cell apoptosis, and inflammatory remodeling. This article places its CDK7–RNAPII mechanism alongside new findings on cell-cycle-regulated transcription condensates, while outlining practical assay design, evidence boundaries, and opportunities for more predictive cancer research.

• CD40–STING–TRAF2 Control of B Cells in ESCC

  2026-08-18

  A 2025 study links tertiary lymphoid structures in treatment-naïve esophageal squamous cell carcinoma with favorable survival and identifies IRF4-positive B-cell activation as a mechanistic feature. Its central model proposes that CD40 and STING compete for TRAF2, reshaping noncanonical NF-κB signaling and promoting IRF4 expression, with implications for biomarkers and immune-mechanism studies.

• PMSF: Protease Control for Translational Signaling

  2026-08-18

  Phenylmethanesulfonyl fluoride (PMSF) is more than a routine lysis-buffer additive: it is a selective control point for protecting protein readouts in inflammatory, apoptosis, and signaling studies. This article explains how to use PMSF rigorously alongside the IL-6/STAT3 gouty arthritis evidence while avoiding the common mistake of treating it as a direct inhibitor of metalloproteases such as MMP-3.

• PKH26 Red Fluorescent Cell Linker Kit Guide

  2026-08-17

  The PKH26 Red Fluorescent Cell Linker Kit supports stable red fluorescent labeling of cell membranes for longitudinal tracing and proliferation studies. It is intended for cell membrane lipid regions in in vitro and in vivo workflows, not for intracellular targets or non-membrane structures.

• Taxus chinensis Fruit, TLR4, and Neuroinflammation

  2026-08-17

  A 2025 Journal of Ethnopharmacology study shows that Taxus chinensis fruit extract reduces aging-associated behavioral deficits, oxidative stress, and hypothalamic neuroinflammation in a D-galactose mouse model. By combining animal studies, LPS-stimulated BV2 microglia, UPLC-MS/MS, and molecular docking, the work links the extract’s effects to coordinated suppression of the TLR4/NF-κB/NLRP3 axis while identifying candidate bioactive constituents.

• Dantrolene Sodium Salt: RyR Antagonist Guide

  2026-08-16

  Dantrolene sodium salt is a ryanodine receptor antagonist that modulates intracellular calcium release, with a supplier-reported RyR2 IC50 of 5.9 ± 0.3 nM. Evidence supports its use as a mechanistic calcium signaling modulation tool, while pancreatitis and CRISPR applications require model-specific validation.

454 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page